Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Ophthalmic Genet. 2016 Jun 29;38(3):222–225. doi: 10.1080/13816810.2016.1193883

CLINICAL AND GENETIC CHARACTERIZATION OF A LARGE PRIMARY OPEN ANGLE GLAUCOMA PEDIGREE

Mohideen Abdul Kader 1,2, Prasanthi Namburi 3, Sarika Ramugade 1, R Ramakrishnan 1,2, Subbiah R Krishnadas 1,4, Ben R Roos 5,6, Sundaresan Periasamy 1, Alan L Robin 7,8, John H Fingert 5,6
PMCID: PMC5329139  NIHMSID: NIHMS849221  PMID: 27355837

Abstract

Purpose

To both characterize the clinical features of large primary open angle glaucoma (POAG) pedigree from a village in Southern India and to investigate the genetic basis of their disease.

Materials and Methods

Eighty-four members of a large pedigree received complete eye examinations including slit lamp examination, tonometry, gonioscopy, and ophthalmoscopy. Some were further studied with perimetry. Those diagnosed with POAG were tested for disease-causing mutations in the myocilin and optineurin genes with Sanger sequencing.

Results

Fourteen of 84 family members were diagnosed with POAG, while 8 were clincially judged to be POAG-suspects. The family structure and the pattern of glaucoma in the pedigree are complex. Features of glaucoma in this pedigree include relatively early age at diagnosis (mean 50 ± 14 years) and maximum intraocular pressures ranging from 14 to 36 mm Hg with a mean of 23 mm Hg ± 6.5 mm Hg. Patients had an average central corneal thickness (mean 529 ± 37.8 microns) and moderate cup-to-disc ratios (0.74 ± 0.14). No mutations were detected in myocilin, optineurin, or TANK binding kinase 1 (TBK1).

Conclusions

We report a five-generation pedigree with a complex pattern of POAG inheritance that includes 22 POAG patients and glaucoma-suspects. Although the familial clustering of POAG in this pedigree is consistent with dominant inheritance of a glaucoma-causing gene, mutations were not detected in genes previously associated with autosomal dominant glaucoma, suggesting the involvement of novel disease-causing gene in this pedigree.

Introduction

Glaucoma afflicts millions in India and is a common cause of blindness. In 2002, an estimated 6.7 million Indians were blind due to glaucoma.1 The prevalence of glaucoma in India has been estimated to be 1.6% to 4.0%24 and the majority of glaucoma in India is classified as primary open angle glaucoma (POAG).3 Glaucoma and POAG are clearly important public health problems in India.

Primary open angle glaucoma (POAG) has a strong genetic component to its pathogenesis and is highly heterogeneous.5 Some forms of POAG are caused by the combined action of many genetic risk factors. Genome-wide association studies have identified many such genetic risk factors for POAG, including CAV1/CAV2,6 CDKN2B-AS1,710 TMCO1,11 ATOH7,7 SIX1/SIX6,7,10 GAS7,11 chromosome 8q22 locus,9 ABCA1,12,13 AFAP1,12 GMDS,12 PMM2,13 FNDC3B,14,15 TFGBR3,16 TXNRD2,17 ATXN2,17 and FOXC1I.17 While these variants are commonly detected in healthy individuals, they are observed at statistically higher frequencies in glaucoma patients. Other forms of glaucoma are caused primarily by mutations in a single gene, such as myocilin (MYOC),18 optineurin (OPTN),19 or TANK binding kinase 1 (TBK1).20 Each of these genes was discovered with studies of large pedigrees that have autosomal dominant inheritence of POAG. In the current study, we report clinical characterization of another large POAG pedigree with Egyptian heritage from Southern India (Tamil Nadu). Genetic analyses were also conducted to determine if the gene that causes disease in this family could be identified.

Materials and methods

POAG subjects and controls

Informed consent was obtained from all family members after explanation of the nature and possible consequences of the study. The study protocol was approved by the Institutional Review Board at the University of Iowa, the Aravind Medical Research Foundation / Aravind Eye Hospitals. This study followed the tenets of the Declaration of Helsinki. After screening 240 people during a field trip to Kayalpatanam, a total of 84 members of a single family were enrolled (Figure 1). All the family members underwent comprehensive ocular examination which included applanation tonometry, pachymetry, slit-lamp examination, gonioscopy, and optic disc examination with 90 D lens. Eleven family members diagnosed with glaucoma or that were judged to be glaucoma suspects were further evaluated at the Aravind Eye Care System and Institute of Ophthalmology at Tirunelveli, Tamil Nadu, where additional testing was conducted including standard automated perimetry with a Humphrey Visual Field Analyser (Zeiss-Humphrey Systems, Dublin, CA) using SITA 24-2 and 10-2 algorithms. Family members with open angles on gonioscopy (Shaffer grade III or IV) and glaucomatous optic disc cupping and corresponding visual field defects were diagnosed with POAG as previously described.21 Elevated IOP was not required for a diagnosis of POAG. Exclusion criteria included potential causes of secondary glaucoma: pigment dispersion syndrome, exfoliation syndrome, inflammation, ocular trauma, ocular surgiers, or developmental abnormalities. Patients were judged to be glaucoma suspects if they did not meet threshold criteria for POAG but had ocular hypertension (IOP > 21 mm Hg), or had suspicious appearing optic discs or suspicious visual fields.

Figure 1. POAG pedigree with Southern India.

Figure 1

Family members diagnosed with POAG are indicated with symbols shaded black, while those that are glaucoma suspect are indicated with symbols shaded grey. Family members and spouses that had normal eye examinations, didn’t meet criteria for POAG or suspect status are indicated with a symbol shaded white.

Sample Preparation and Mutation Screening

A volume of 5 to 10 ml of peripheral venous whole blood samples were collected in EDTA by venipuncture tube from each participant. We extracted DNA using the salt precipitation method as previously described.22 The isolated DNA was quantified and further preceded for mutational screening known candidate genes (MYOC, OPTN by bi-directional Sanger sequencing and TBK1 by qPCR) as previously described.21,23,24

Statistical analysis

Age, maximum IOP, CCT (average between eyes), and cup-to-disc ratio were compared using two-tailed unpaired T-test. Threshold for significance was set at p =0.05.

Results

Clinical characteristics of glaucoma in the pedigree

A total of 84 members of a large family from Southern India, all with Egyptian heritage (Figure 1), had complete ophthalmic examinations. Fourteen of the 84 family members were diagnosed with POAG, while 8 family members were judged to be glaucoma suspects (Figure 1). Clinical features of these family members are described in Table 1. The POAG in this family has a relatively early age of onset with a mean of 50 ± 14 years and a range of 23 to 68 years. The maximum recorded IOP in family members with POAG ranged from 14 to 36 mm Hg with a mean of 22.5 ± 6.5 mm Hg. Six (43%) of the 14 family members with POAG had a maximum recorded IOP < 21 mm Hg. Central corneal thickness (CCT) in family members with POAG had a mean value of 529 ± 37.8 microns and cup-to-disc ratios at first examination (mean of OD and OS) ranged from 0.6 to 0.9 with a mean of 0.74 ± 0.14. Moderate to severe visual field loss was detected with SITA 24-2 and 10-2 testing algorithms with a Humphrey Visual Analyser.

Table 1. Clinical features of family members diagnosed with POAG.

Most family members were tested with the SITA 24-2 algorithm on the Humphrey Field analyser, however, two family members indicated with asterisks were tested with the 10-2 algorithm. The mean values for the visual field tests are for those using the 24-2 algorithm only.

Pedigree Symbol Age at Diagnosis (years) Max IOP (mm Hg) CCT (microns) Cup-To-Disc Ratio at First Exam Humphrey Visual Field Analyser Data (SITA 24-2 / 10-2*) Glaucoma Surgeries Co-Morbidity
OD OS MD OD (dB) PSD OD (dB) MD OS (dB) PSD OS (dB)
III-2 23 24 522 0.7 0.4 −2.89 8.07 −0.26 1.10 None None
III-3 34 26 527 0.7 0.8 −8.36 8.36 −10.37 10.01 None None
II-2 65 15 506.5 0.8 0.8 −6.05 2.42 −9.05 4.93 None None
III-20 45 21 565.5 0.7 0.6 −7.32 4.07 −9.64 5.71 None None
III-21 40 14 519 0.6 0.6 NA NA NA NA None None
II-5 56 17 NA 0.9 NA NA NA NA NA Trabeculectomy CRVO
III-19 51 24 552 0.5 0.6 −8.8 6.61 −10.09 8.37 None None
III-32 NA 26 519 0.9 0.9 NA NA NA NA None None
IV-26 NA 36 528.5 0.9 0.9 NA NA NA NA Trabeculectomy CRVO
IV-27 NA 18 617 0.8 0.8 NA NA NA NA None None
III-38 68 22 535 0.6 0.6 −3.63 1.63 −4.42 2.24 None None
III-26 66 18 486 0.8 0.8 −14.24* 8.12* −12.56* 9.56* None CRVO
III-25 48 20 470 0.9 NA −26.62* 9.97* NA NA Trabeculectomy CRVO
II-15 53 34 NA NA 0.9 NA NA −23.57 8.25 Trabeculectomy CRVO
Mean 50 22.5 529 0.74 −6.18 5.19 −9.63 5.80 NA NA
Std Dev 14 6.5 37.8 0.14 2.46 2.90 7.19 3.31

Abbreviations: primary open angle glaucoma (POAG), intraocular pressure (IOP), central corneal thickness (CCT), Swedish interactive threshold algorithm (SITA), mean deviation (MD), pattern standard deviation (PSD), not available (NA), central retinal vein occlusion (CRVO).

Eight of 14 family members (Figure 1) were judged to be glaucoma-suspects because their examinations were suggestive of glaucoma, but did not meet threshold for a diagnosis of disease. The clinical features of the glaucoma suspects are described in Table 2. The maximum IOP of the glaucoma suspects ranged from 13 to 22 mm Hg and the mean maximum IOP of 18.0 ± 2.7 mm Hg is nominally lower than the mean maximum IOP of POAG patients, 22.5 ± 6.5 mm Hg (p = 0.079). The glaucoma suspects in the family had a mean CCT of 554 ± 37.9 microns which is nominally thicker than CCT of the POAG patients, 529 ±37.9 microns (p = 0.16). The cup-to-disc ratio of the glaucoma suspects at first examination (mean of OD and OS) was 0.59 ± 0.088 which is significantly smaller than the mean cup-to-disc ratio of the family members with POAG, 0.74 ± 0.14 (p = 0.00064).

Table 2.

Clinical features of family members that are glaucoma suspects.

Pedigree Symbol Age at Diagnosis (years) Max IOP (mm Hg) CCT (microns) Cup-To-Disc Ratio at First Exam Humphrey Visual Field Analyzer Data (SITA 24-2)
OD OS MD OD (dB) PSD OD (dB) MD OS (dB) PSD (dB)
III-15 51 19 552 0.6 0.65 NA NA NA NA
II-4 58 20 552 0.6 0.6 −6.71 4.997 −12.76 10.02
III-9 40 16 601 0.6 0.6 NA NA NA NA
III-11 36 19 601 0.65 0.65 NA NA NA NA
III-36 45 22 545 0.6 0.6 −3.7 1.19 −3.28 1.43
III-30 52 13 527 0.6 0.3 0.91 1.41 0.7 1.47
III-28 49 18 486 0.6 0.7 −3.17 2.85 −3.86 1.34
III-40 43 17 568 0.6 0.5 NA NA NA NA
Mean 47 18.0 554 0.59 −3.17 2.61 −4.80 3.57
Std Dev 7.1 2.7 37.9 0.088 3.13 1.75 5.68 4.30

Abbreviations: intraocular pressure (IOP), central corneal thickness (CCT), Swedish interactive threshold algorithm (SITA), mean deviation (MD), pattern standard deviation (PSD), not available (NA).

Known candidate gene screening

Patients of this pedigree with POAG had maximum recorded IOPs that ranged from 14 to 36 mm Hg and 6 (43%) of 14 patients have never had a measured IOP > 21. Consequently, members of this pedigree were tested for disease-causing mutations in genes previously associated with POAG with high IOP (myocilin) and in genes previously associated with POAG with low IOP (optineurin and TBK1).

All 14 family members with POAG were tested for myocilin mutations with Sanger sequencing. One non-synonymous variant (Arg76Lys) was detected in the myocilin gene, which has been previously reported as a benign, non-disease-causing variant.21 POAG patients were also tested for the glaucoma-causing optineurin mutation (Glu50Lys),19 however, this variant was not detected. Finally, the family members with POAG were tested for the previously reported copy number variations (duplications and triplications) of the TBK1 gene that are associated with normal tension glaucoma.20 No TBK1 copy number variations were detected.

Discussion

This family has POAG with variable clinical features of age at diagnosis and maximum IOP (Table 1). Although the average age at diagnosis was 50 years and most family members were diagnosed with POAG in their fifth or six decade, others were diagnosed at an earlier age (i.e. at 23 and 34 years old). Similarly, members of this pedigree with POAG had a mean maximum IOP of 22.5 mm Hg, but six (43%) of these family members never had an IOP recorded over 21 mm Hg. While members of this glaucoma pedigree together have average ages at diagnosis and average maximum IOPs typical for a diagnosis of POAG, some members have an onset before age 40 years which is suggestive of juvenile-onset open angle glaucoma. Likewise most family have maximum IOPs greater than 21 mm Hg, but a sizeable fraction, 43%, have maximum IOPs less than 21 mm Hg consistent with diagnosis of normal tension glaucoma. This variability in age at diagnosis and maximum IOP is not uncommon among large glaucoma pedigrees. However, it is possible, although less likely, that disparate phenotypes may suggest that one or more family members is a pheonocopy (i.e. has a different cause of glaucoma than the rest of the family).

Pedigrees with many (i.e. more than ten) family members diagnosed with POAG are rare, but several have been reported.19,20,2532 The POAG in each of these large pedigrees has a relatively early age at diagnosis and is inherited in an autosomal dominant pattern. Genetic studies of these pedigrees have had a profound influence on the investigation of glaucoma pathogenesis. Studies of one group of these large POAG pedigrees ultimately led to the discovery that mutations in myocilin gene cause 4% of POAG cases.18,21 Subsequent studies of myocilin biology in human patients, organ culture systems, and transgenic mice suggest that some cases of glaucoma are caused by accumulation of abnormal myocilin protein within trabecular meshwork cells.3335 Genetic studies of other large POAG families similarly led to the discovery of optineurin19 and TBK120 as glaucoma-causing genes and have implicated defects in auotphagy as another important mechanism in glaucoma pathogenesis. Consesquently, there is great interest in characterizing the clinical features of POAG pedigrees such as ours (Figure 1) and searching for the genes that cause their glaucoma. This current report shows that our large POAG pedigree does not harbor mutations in the three genes currently known to cause POAG and suggests that further studies of this pedigree have the potential to identify a new glaucoma-causing gene.

References

  • 1.Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851. [PMC free article] [PubMed] [Google Scholar]
  • 2.Dandona L, Dandona R, Srinivas M, et al. Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology. 2000;107(9):1702–1709. doi: 10.1016/s0161-6420(00)00275-x. [DOI] [PubMed] [Google Scholar]
  • 3.Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1484–1490. doi: 10.1016/S0161-6420(03)00564-5. [DOI] [PubMed] [Google Scholar]
  • 4.Garudadri C, Senthil S, Khanna RC, Sannapaneni K, Rao HBL. Prevalence and Risk Factors for Primary Glaucomas in Adult Urban and Rural Populations in the Andhra Pradesh Eye Disease Study. Ophthalmology. 2010;117(7):1352–1359. doi: 10.1016/j.ophtha.2009.11.006. [DOI] [PubMed] [Google Scholar]
  • 5.Fingert JH. Primary open-angle glaucoma genes. Eye. 2011;25(5):587–595. doi: 10.1038/eye.2011.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wiggs JL, Kang JH, Yaspan BL, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet. 2011;20(23):4707–4713. doi: 10.1093/hmg/ddr382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ramdas WD, van Koolwijk LME, Lemij HG, et al. Common genetic variants associated with open-angle glaucoma. Hum Mol Genet. 2011;20(12):2464–2471. doi: 10.1093/hmg/ddr120. [DOI] [PubMed] [Google Scholar]
  • 8.Nakano M, Ikeda Y, Tokuda Y, et al. Common variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in Japanese. PLoS ONE. 2012;7(3):e33389. doi: 10.1371/journal.pone.0033389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wiggs JL, Yaspan BL, Hauser MA, et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet. 2012;8(4):e1002654. doi: 10.1371/journal.pgen.1002654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Osman W, Low S-K, Takahashi A, Kubo M, Nakamura Y. A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma. Hum Mol Genet. 2012;21(12):2836–2842. doi: 10.1093/hmg/dds103. [DOI] [PubMed] [Google Scholar]
  • 11.van Koolwijk LME, Ramdas WD, Ikram MK, et al. Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet. 2012;8(5):e1002611. doi: 10.1371/journal.pgen.1002611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gharahkhani P, Burdon KP, Fogarty R, et al. Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet. 2014;46(10):1120–1125. doi: 10.1038/ng.3079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chen Y, Lin Y, Vithana EN, et al. Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma. Nat Genet. 2014 Aug; doi: 10.1038/ng.3078.. [DOI] [PubMed] [Google Scholar]
  • 14.Hysi PG, Cheng C-Y, Springelkamp H, et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet. 2014;46(10):1126–1130. doi: 10.1038/ng.3087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lu Y, Vitart V, Burdon KP, et al. Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet. 2013;45(2):155–163. doi: 10.1038/ng.2506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Li Z, Allingham RR, Nakano M, et al. A common variant near TGFBR3 is associated with primary open angle glaucoma. Hum Mol Genet. 2015;24(13):3880–3892. doi: 10.1093/hmg/ddv128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bailey JNC, Loomis SJ, Kang JH, et al. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat Genet. 2016;48(2):189–194. doi: 10.1038/ng.3482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Stone EM, Fingert JH, Alward WLM, et al. Identification of a Gene That Causes Primary Open Angle Glaucoma. Science. 1997;275(5300):668–670. doi: 10.1126/science.275.5300.668. [DOI] [PubMed] [Google Scholar]
  • 19.Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295(5557):1077–1079. doi: 10.1126/science.1066901. [DOI] [PubMed] [Google Scholar]
  • 20.Fingert JH, Robin AL, Ben R, Roos, et al. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet. 2011;20(12):2482–2494. doi: 10.1093/hmg/ddr123.. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fingert JH, Héon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8(5):899–905. doi: 10.1093/hmg/8.5.899. [DOI] [PubMed] [Google Scholar]
  • 22.Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Alward WLM, Kwon YH, Kawase K, et al. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol. 2003;136(5):904–910. doi: 10.1016/s0002-9394(03)00577-4. [DOI] [PubMed] [Google Scholar]
  • 24.Ritch R, Darbro B, menon G, et al. TBK1 Gene Duplication and Normal-Tension Glaucoma. JAMA ophthalmology. 2014;132(5):544–548. doi: 10.1001/jamaophthalmol.2014.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Johnson AT, Drack AV, Kwitek AE, Cannon RL, Stone EM, Alward WL. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology. 1993;100(4):524–529. doi: 10.1016/s0161-6420(13)31615-7. [DOI] [PubMed] [Google Scholar]
  • 26.Johnson AT, Richards JE, Boehnke M, et al. Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome 1q. Ophthalmology. 1996;103(5):808–814. doi: 10.1016/s0161-6420(96)30611-8. [DOI] [PubMed] [Google Scholar]
  • 27.Monemi S, Spaeth G, DaSilva A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet. 2005;14(6):725–733. doi: 10.1093/hmg/ddi068. [DOI] [PubMed] [Google Scholar]
  • 28.Wirtz MK, Samples JR, Rust K, et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35–q36. Arch Ophthalmol. 1999;117(2):237–241. doi: 10.1001/archopht.117.2.237. [DOI] [PubMed] [Google Scholar]
  • 29.Wiggs JL, Del Bono EA, Schuman JS, Hutchinson BT, Walton DS. Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21–q31. Ophthalmology. 1995;102(12):1782–1789. doi: 10.1016/s0161-6420(95)30793-2. [DOI] [PubMed] [Google Scholar]
  • 30.Wiggs JL, Haines JL, Paglinauan C, Fine A, Sporn C, Lou D. Genetic linkage of autosomal dominant juvenile glaucoma to 1q21–q31 in three affected pedigrees. Genomics. 1994;21(2):299–303. doi: 10.1006/geno.1994.1269. [DOI] [PubMed] [Google Scholar]
  • 31.Richards JE, Lichter PR, Boehnke M, et al. Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq. Am J Hum Genet. 1994;54(1):62–70. [PMC free article] [PubMed] [Google Scholar]
  • 32.Morissette J, Côté G, Anctil JL, et al. A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q. Am J Hum Genet. 1995;56(6):1431–1442. [PMC free article] [PubMed] [Google Scholar]
  • 33.Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10(2):117–125. doi: 10.1093/hmg/10.2.117. [DOI] [PubMed] [Google Scholar]
  • 34.Zode GS, Kuehn MH, Nishimura DY, et al. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest. 2011;121(9):3542–3553. doi: 10.1172/JCI58183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kwon YH, Fingert JH, Kuehn MH, Alward WLM. Primary Open-Angle Glaucoma. N Engl J Med. 2009;360(11):1113–1124. doi: 10.1056/NEJMra0804630. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES